Search PGNY
Progyny, Inc.
Nasdaq · CIK 1551306
Last close25.23
Daily change+0.38 (1.53%)
10 Years gain+58.28%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
PGNY · STANDARD
SIC 8090 · Services-Misc Health & Allied Services, NEC · Fiscal year end 1231
Fundamental
85.5Momentum
61.9Acceleration
77.1Confidence
91.0Annual Revenue6
Quarterly Revenue23
Annual CFO9
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth18.2 / 25
Quality19.0 / 25
Capital Efficiency19.1 / 20
Balance Sheet15.0 / 15
Shareholder Economics10.0 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 2.2335 percentage points.
Operating leverageOperating margin improved by 2.3731 percentage points.
ROIC expansionROIC improved by 10.1244 percentage points.
Share count reductionDiluted share count declined 8.3639%.
Strong operating leverageOperating income is growing faster than revenue while operating margin expands.
Key Metrics
Revenue Growth TTM5.54%OK
Revenue CAGR 3Y17.87%OK
Gross Margin24.57%OK
Operating Margin8.55%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC34.52%OK
Incremental Operating Margin 3Y21.76%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y-8.36%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $1.29B | $304.48M | $85.28M | $210.19M | $191.78M | 23.63% | 6.62% | 14.88% | 27.71% | 89.86M |
| 2025 FY Dec 31, 2024 | $1.17B | $253.36M | $67.46M | $179.11M | $173.70M | 21.71% | 5.78% | 14.88% | 23.4% | 95.45M |
| 2025 FY Dec 31, 2023 | $1.09B | $238.80M | $62.18M | $188.81M | $185.17M | 21.94% | 5.71% | 17.01% | 29.5% | 100.67M |
| 2024 FY Dec 31, 2022 | $786.91M | $167.33M | $23.34M | $80.40M | $77.15M | 21.26% | 2.97% | 9.8% | 11.05% | 99.96M |
| 2023 FY Dec 31, 2021 | $500.62M | $112.14M | $32.34M | $26.04M | $23.91M | 22.4% | 6.46% | 4.78% | 22.12% | 100.36M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $1.31B | sum latest 4 fiscal quarters Revenue | OK | 0001551306-26-000020, 0001551306-26-000068 |
| Revenue Growth TTM | 5.54% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001551306-26-000020, 0001551306-26-000068 |
| Revenue CAGR 3Y | 17.87% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001551306-26-000020 |
| Revenue CAGR 5Y | 30.17% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001551306-26-000020 |
| Gross Profit CAGR 3Y | 22.09% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001551306-26-000020 |
| Operating Income Growth | 46.06% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001551306-26-000020, 0001551306-26-000068 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 24.57% | Gross Profit / Revenue | OK | 0001551306-26-000020, 0001551306-26-000068 |
| Operating Margin | 8.55% | Operating Income / Revenue | OK | 0001551306-26-000020, 0001551306-26-000068 |
| ROIC | 34.52% | NOPAT / Average Invested Capital | OK | 0001551306-26-000020, 0001551306-26-000068 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001551306-26-000140 |
| Current Ratio | 2.14x | Current Assets / Current Liabilities | OK | derived |
| Revenue per Diluted Share | $15.96 | Revenue / Diluted Shares | OK | 0001551306-26-000020, 0001551306-26-000068 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |